Patents Assigned to Ascensia Diabetes Care Holdings AG
  • Patent number: 11361863
    Abstract: Embodiments provide systems, methods and apparatus for diabetes management using location-based reminders. Embodiments include requesting a user select a diabetes management related task to be reminded to perform; requesting the user select a location at which the user is to be reminded to perform the selected diabetes management related task; monitoring the user's location; detecting the user has entered the selected location; triggering the reminder in response to detecting the user has entered the selected location; and presenting the reminder to the user. Numerous other aspects are provided like helping a user locate a blood glucose meter (BGM) by identifying a most recent data transfer from the BGM based on a stored date and time associated with the most recent data transfer from the BGM, and identifying patterns of diabetes management events corresponding to particular location types.
    Type: Grant
    Filed: April 29, 2016
    Date of Patent: June 14, 2022
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Jennifer L. Gass, Michael Harboun, Simon King
  • Patent number: 11353417
    Abstract: Methods, devices, and systems are disclosed for the determination and logging of risk factor parameters associated with a sample, in association with the measurement of a concentration of an analyte in the sample. The methods, devices, and systems provide for applying an input signal to a sample via an electrode. The input signal has at least one excitation. The methods, devices, and systems further provide for measuring an output signal responsive to the input signal. The methods, devices, and systems further provide for determining a concentration of an analyte within the sample based on the output signal, and determining at least one risk factor parameter associated with at least one species in the sample other than the analyte.
    Type: Grant
    Filed: December 1, 2017
    Date of Patent: June 7, 2022
    Assignee: ASCENSIA DIABETES CARE HOLDINGS AG
    Inventor: Huan-Ping Wu
  • Patent number: 11298470
    Abstract: Embodiments provide systems, methods, and apparatus for a medication delivery device. The device includes a dose selector for selecting an amount of medication to deliver; a first capacitive sensor adjacent the dose selector and operative to detect linear displacement of the dose selector during medication delivery; a screw coupled to the dose selector; a second capacitive sensor adjacent the screw and operative to detect linear displacement of the screw during medication delivery; and a processor coupled to the first and second capacitive sensors and operative to determine an amount of medication actually delivered by the medication delivery device. Numerous other aspects are provided.
    Type: Grant
    Filed: October 26, 2017
    Date of Patent: April 12, 2022
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Nikhil M. Shah, Eugene R. Prais, Nihir Patel, Jennifer L. Gass, Megan M. Burkarski
  • Patent number: 11268925
    Abstract: Devices and methods for determining one or more analyte concentrations in a sample, determining a sample type, and/or accounting for interference species in a sample are disclosed that include intertwining a first input signal, via a first electrode having a reagent, with a second input signal, via a second electrode lacking a reagent, by applying to the sample the first input signal having at least two excitations and a relaxation, and applying to the sample the second input signal having at least two excitations and a relaxation, such that the excitations of the first input signal are nonconcurrent with the excitations of the second input signal. The method further includes measuring a first output signal responsive to the first input signal and a second output signal responsive to the second input signal.
    Type: Grant
    Filed: July 7, 2017
    Date of Patent: March 8, 2022
    Assignee: ASCENSIA DIABETES CARE HOLDINGS AG
    Inventors: Huan-Ping Wu, Mary Ellen Warchal-Windham, Bern Everett Harrison, Nicole D. Ellis
  • Patent number: 11253175
    Abstract: Embodiments provide apparatus, systems, and methods for communicating analyte data and/or related information. In a first aspect, the apparatus includes a transmitter/receiver unit which is configurable as either a transmitter or a receiver. The transmitter/receiver unit may be coupled to an on-body sensor and may be configured as a transmitter, or may be coupled to a management unit and may be configured as a receiver as part of a continuous analyte monitoring system. Analyte data communication systems and methods are provided, as are other aspects.
    Type: Grant
    Filed: December 28, 2018
    Date of Patent: February 22, 2022
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Hoi-Cheong Steve Sun, Paul M. Ripley, Mu Wu
  • Patent number: 11237152
    Abstract: A wireless transmitter adapter (206) can provide wireless data transmission capability to a battery-operated biosensor meter (100), such as a blood glucose meter, originally configured for hardwired data downloads. In some embodiments, the wireless transmitter adapter (206) can be configured to replace a bio-sensor meter's battery cover (106). The wireless transmitter adapter (206) can include wireless transmitter circuitry (700), a connector (218) configured to be received in a biosensor meter's communications port (112) to electrically couple to the meter's processor circuitry (107), and one or more electrical contacts (625a, 625b) configured to electrically couple to the biosensor meter's one or more batteries (102a, 102b) to power the wireless transmitter circuitry (700).
    Type: Grant
    Filed: April 9, 2015
    Date of Patent: February 1, 2022
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Raymond L. Yao, Lauren N. Bock, Igor Y. Gofman
  • Patent number: 11226327
    Abstract: A test sensor container for use with an analyte measuring system may include a cartridge that includes a base, two opposite sidewalls extending away from the base, and a plurality of compartments each dimensioned to hold a test sensor. At least one of the two opposite sidewalls is oriented at an acute angle relative to a reference axis that is perpendicular to the base. The test sensor container may further include at least one foil cover sealing the plurality of compartments and an ejection mechanism.
    Type: Grant
    Filed: March 21, 2016
    Date of Patent: January 18, 2022
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Daniel Brown, Martin Antoine Mathelier, Sung-Kwon Jung
  • Patent number: 11215578
    Abstract: In some aspects, an analyte sensor is provided for detecting an analyte concentration level in a bio-fluid sample. The analyte sensor has a base, a first electrode and a second electrode wherein a thermocouple portion is provided integral with the second electrode thereby enabling on-sensor temperature measurement capability. In some embodiments, two and only two electrical contact engagement portions are provided thereby simplifying electrical contact. Manufacturing methods and systems utilizing the analyte sensors are provided, as are numerous other aspects.
    Type: Grant
    Filed: June 27, 2017
    Date of Patent: January 4, 2022
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Hoi-Cheong Steve Sun, John P. Creaven, Mu Wu, Paul M. Ripley, Steven C. Charlton
  • Patent number: 11180790
    Abstract: A reagent for detecting an analyte comprises a flavoprotein enzyme, a mediator such as a phenothiazine mediator, at least one surfactant, a polymer and a buffer. The reagent may be used with an electrochemical test sensor that includes a plurality of electrodes.
    Type: Grant
    Filed: May 13, 2020
    Date of Patent: November 23, 2021
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Amy H. Chu, Karen L. Marfurt, Brenda L. Tudor, Mary Ellen Warchal-Windham, Boru Zhu
  • Patent number: 11094402
    Abstract: A portable data-management system may be easily employed with multiple processing devices by eliminating the need to pre-install additional programs, agents, device drivers, or other software components on the hosts. A portable storage device contains software for a data-management application, which receives and processes test data from a meter that measures an analyte. The portable device may employ an interface protocol that makes the portable device immediately compatible with different operating systems and hardware configurations. Once the portable device is connected to the host, the data-management application can be automatically launched. The convenience and portability of a data-management system may be enhanced by integrating advanced data processing and display features with the portable device. The users may access some advanced presentations of health data without having to launch the data-management application on a separate host.
    Type: Grant
    Filed: May 31, 2017
    Date of Patent: August 17, 2021
    Assignee: ASCENSIA DIABETES CARE HOLDINGS AG
    Inventors: Darren Brown, Jun Chen, Igor Gofman, Steven B. Harris, Paul L. Inman, Richard Kates, Qiong Li, Harris Lieber, Paul M. Ripley, Gregory Stefkovic, Hoi-Cheong Steve Sun, Mu Wu, Raymond Yao, Simin Yao
  • Patent number: 11091790
    Abstract: A biosensor system determines an analyte concentration of a biological sample using an electrochemical process without Cottrell decay. The biosensor system generates an output signal having a transient decay, where the output signal is not inversely proportional to the square root of the time. The transient decay is greater or less than the ?0.5 decay constant of a Cottrell decay. The transient decay may result from a relatively short incubation period, relatively small sample reservoir volumes, relatively small distances between electrode surfaces and the lid of the sensor strip, and/or relatively short excitations in relation to the average initial thickness of the reagent layer. The biosensor system determines the analyte concentration from the output signal having a transient decay.
    Type: Grant
    Filed: December 14, 2018
    Date of Patent: August 17, 2021
    Assignee: ASCENSIA DIABETES CARE HOLDINGS AG
    Inventors: Huan-Ping Wu, Steven C. Charlton, Amy H. Chu, Andrew J. Edelbrock, Sung-Kwon Jung, Dijia Huang
  • Patent number: 11064334
    Abstract: Some embodiments of the present invention include placing a smart device and a peripheral device in pairing mode; detecting at least one pairing motion event with a dual use piezo circuit within the peripheral device; transmitting an indication of the occurrence of the at least one pairing motion event to the smart device; receiving in the smart device the indication of the occurrence of the at least one pairing motion event in satisfaction of at least one pairing condition; and pairing the smart device with the peripheral device in response to satisfaction of the at least one pairing condition. Numerous other aspects are provided.
    Type: Grant
    Filed: January 18, 2019
    Date of Patent: July 13, 2021
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Igor Y. Gofman, Christopher A. Dionisio
  • Patent number: 11015984
    Abstract: A system and method for rapidly determining ambient temperature in a fluid-analyte meter. The meter includes a housing defining an interior space and an area for receiving a fluid sample. A processor and a first temperature sensor are disposed within the interior space of said the housing. A second temperature sensor is disposed on the housing. One or more processors are configured to determine a first temperature value from temperature data received from the first temperature sensor. The processor(s) are also configured to apply a variable current to a temperature-adjustment source such that the second temperature sensor is adjusted to a predetermined steady-state temperature value different from the first temperature value. The processor(s) are further configured to determine an ambient temperature of an exterior space of the housing based on the applied variable current, pre-determined steady-state temperature, and received first temperature values.
    Type: Grant
    Filed: October 16, 2019
    Date of Patent: May 25, 2021
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventor: Mu Wu
  • Patent number: 11013408
    Abstract: According to one aspect of the present invention, a sensor for diagnosing a physiological or physical state includes a measurement system configured to determine clinical data for one or more parameters related to the physiological or physical state, a first memory configured to store the clinical data, a transmitter configured to transmit the clinical data according to a first communications protocol, a receiver configured to receive enhanced data according to a second communications protocol, and a second memory configured to store the enhanced data. The enhanced data is based on the clinical data.
    Type: Grant
    Filed: March 18, 2015
    Date of Patent: May 25, 2021
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Todd T. Swanzey, Gregory Stefkovic, Christopher Dionisio
  • Patent number: 10988610
    Abstract: An electrochemical sensor system comprises an electrochemical sensor and a hydrogel composition. The electrochemical sensor has at least a counter electrode and a working electrode. The hydrogel composition contacts the working electrode. The hydrogel composition comprises a first monomer, a second monomer, a cross-linking agent, and a solvent. The first monomer has hydrophilic characteristics. The second monomer has hydrophobic characteristics. The ratio of the first monomer to the second monomer is from about 0.1:99.9 to about 99.9:0.1.
    Type: Grant
    Filed: April 14, 2020
    Date of Patent: April 27, 2021
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Paul Valint, Jr., Doug H. Williamson, Boru Zhu
  • Patent number: 10989683
    Abstract: A sensor system including devices and methods for determining the concentration of an analyte in a sample is described. Input signals including amperometric and voltammetric duty cycles of excitations and relaxations may provide a shorter analysis time and/or improve the accuracy and/or precision of the analysis. The disclosed system may reduce analysis errors, thus improving measurement performance, by adjusting the potential and/or scan rate in response to output currents obtained from voltammetric scans. The disclosed system also may determine the concentration of more than one ionizable species in the sample by adjusting the potential and/or scan rate in response to output currents obtained from voltammetric scans. The multiple, determined concentrations may be used to determine the concentration of multiple analytes or to correct the concentration determined for an analyte, thus improving the measurement performance of the system.
    Type: Grant
    Filed: September 19, 2019
    Date of Patent: April 27, 2021
    Assignee: ASCENSIA DIABETES CARE HOLDINGS AG
    Inventor: Huan-Ping Wu
  • Patent number: 10989611
    Abstract: Methods and systems accurately determine an analyte concentration in a fluid sample. In an example embodiment, a receiving port receives a test sensor. The test sensor includes a fluid-receiving area for receiving a fluid sample. The fluid-receiving area contains a reagent that produces a measurable reaction with an analyte in the fluid sample. The test sensor has a test-sensor temperature and the reagent has a reagent temperature. A measurement system measures the reaction between the reagent and the analyte. A temperature-measuring system measures the test sensor temperature when the test sensor is received into the receiving port. A concentration of the analyte in the fluid sample is determined according to the measurement of the reaction and the measurement of the test sensor temperature. A diagnostic system determines an accuracy of the temperature-measuring system. The calculation of the analyte concentration may be adjusted according to the accuracy of temperature-measuring system.
    Type: Grant
    Filed: January 15, 2019
    Date of Patent: April 27, 2021
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Narasinha Parasnis, Hoi-Cheong Steve Sun, Mu Wu
  • Patent number: 10982251
    Abstract: A method of making an electrochemical sensor strip that includes: depositing a first electrode on a base; depositing a second electrode on the base; applying a first layer onto the first electrode; and applying a second layer onto the second electrode. The first layer includes an oxidoreductase and a mediator. The second layer includes a soluble redox species.
    Type: Grant
    Filed: September 27, 2019
    Date of Patent: April 20, 2021
    Assignee: ASCENSIA DIABETES CARE HOLDINGS AG
    Inventors: Huan-Ping Wu, Greg P. Beer, Christina Blaschke
  • Patent number: 10947328
    Abstract: A non-leaching mediator may include a polymer having a polymeric backbone, and a plurality of phenothiazine groups bonded to the polymeric backbone. The plurality of phenothiazine groups may include at least one of a phenothiazine group having the general formula (IV): and salts thereof, where n is about 9 and “R” represents the polymeric backbone to which the phenothiazine group is bonded, and a phenothiazine group having the general formula (V): and salts thereof, where n is about 9 and “R” represents the polymeric backbone to which the phenothiazine group is bonded.
    Type: Grant
    Filed: April 27, 2020
    Date of Patent: March 16, 2021
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Jiangfeng Fei, William Chiang, Frank Kerrigan, Stuart Green, Craig Robson, Howard Easterfield
  • Patent number: 10948971
    Abstract: Embodiments of the present invention provide systems, apparatus, and methods for powering electronic devices with low voltage batteries. Embodiments include a circuit including a transistor having a base, an emitter, and a collector; a microcontroller having an output port, a system power terminal, and an input port; a first signal generated from the output port of the microcontroller and coupled to an enable pin of a DC-DC booster; and a second signal generated from the output port of the microcontroller and coupled to the base of the transistor, wherein the second signal is an inverted version of the first signal. The emitter of the transistor is coupled to ground and the collector of the transistor is coupled to the enable pin of the DC-DC booster. Numerous additional aspects are disclosed.
    Type: Grant
    Filed: June 1, 2017
    Date of Patent: March 16, 2021
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventor: Igor Y. Gofman